Anthem Bio Files For Rs 3,395-Cr IPO

New Delhi: Anthem Biosciences on Tuesday filed preliminary papers with capital markets regulator Sebi to float a Rs 3,395-crore initial public offering. The proposed initial public offer (IPO) is entirely an offer for sale (OFS) worth Rs 3,395 crore by promoters, investors and other selling shareholders, according to a Draft Red Herring Prospectus (DRHP). Under the OFS, promoters -- Ganesh Sambasivam and K Ravindra Chandrappa, and investors -- Viridity Tone LLP and Portsmouth Technologies LLC – will sell the shares in Anthem Biosciences. Other shareholders -- Malay J Barua, Rupesh N Kinekar, Satish Sharma, Prakash Kariabettan, and K Ramakrishnan will also offload their shares in the company.

Since the IPO is entirely an OFS, the company will not receive any funds from the issue and the proceeds will go to the selling shareholder. Incorporated in 2006, the Bengaluru-based company has two operational manufacturing facilities in Karnataka, with an aggregate annual custom synthesis capacity and fermentation capacity of 270 kL and 142 kL, respectively, as of September 30, 2024.